Breast Cancer with HER2 Overexpression
📧 Sign up to get email alerts when something new happens for Breast Cancer with HER2 Overexpression.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer [Phase 2]
A Phase 2 trial comparing TCH versus EC-TH as neoadjuvant therapy for HER2-positive breast cancer has been completed.